Skip to main content
OpenTrials

Clinical trial condition

HER2 Amplified

Explore clinical trials studying HER2 Amplified. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

HER2 Amplified trial results

Completed

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

NCT02091960

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Site US10051 Anaheim, California, United States
  • Site US10028 Los Angeles, California, United States
  • Site US10035 San Francisco, California, United States
  • Site US10079 Fort Myers, Florida, United States
View all 39 locations
View Trial Details

Related conditions